DSS News and Press, Document Security Systems Inc. From 08/30/22

The NYSE has sent a non-compliance notice to DSS ( NYSE: DSS ) relating to the stock exchange's continued listing requirements under the timely filing criteria. DSS had previously disclosed that it would not be able to timely file the Form 10-Q, and it remained unable to ...

ROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a para...

ROCHESTER, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric sh...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’re starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday! Moving stocks this morning are earnings reports, merger a...

DSS ( NYSE: DSS ) shares popped around 17% after the company announced on Thursday the licensing of Impact BioMedical's Linebacker portfolio to ProPhase Labs ( NASDAQ: PRPH ). Global BioLife, a subsidiary of DSS's wholly-owned subsidiary Impact BioMedical, sign...

The great part (and scary) about penny stocks is their volatility and potential for quickly making huge moves. It isn’t a rarity to see these cheap stocks explode hundreds or even thousands of percentage points in a day or even a few weeks. Our writers have written about many of the ...

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a para...

ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a para...

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and Discovery Group Sciences (GRDG), announced today that it signed a license agreement with Pr...

HENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholder...